Rifaximin-EIR in mild to moderate active Crohnʼs disease (GRACE 02 study)
Lukas, M, Novotny, A, Bortlik, M, Leeder, J, Palazzini, EVolume:
13
Language:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1097/00054725-200705005-00085
Date:
May, 2007
File:
PDF, 53 KB
english, 2007